{"DataElement":{"publicId":"3005331","version":"1","preferredName":"Skin Graft Versus Host Disease Secondary Sign Name","preferredDefinition":"Objective ancillary data related to the signs and symptoms of skin Graft vs Host Disease (GVHD).  This is part of the Chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_ANC_SGN_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3005322","version":"1","preferredName":"Skin Graft Versus Host Disease Secondary Sign","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value._Objective evidence of disease perceptible to the examining physician.","longName":"SKN_GVHD_ANC_SGN","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3005319","version":"1","preferredName":"Skin Graft Versus Host Disease","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.:An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C12470:C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE16-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3005320","version":"1","preferredName":"Secondary Sign","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.:Objective evidence of disease perceptible to the examining physician.","longName":"C25667:C53458","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sign","conceptCode":"C53458","definition":"Objective evidence of disease perceptible to the examining healthcare provider.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE27-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE38-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3005324","version":"1","preferredName":"Skin Graft Versus Host Disease Sign Name","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin._Objective evidence of disease perceptible to the examining physician._The words or language units by which a thing is known.","longName":"SKN_GVHD_SGN_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Xerosis","valueDescription":"Xerosis","ValueMeaning":{"publicId":"3005325","version":"1","preferredName":"Xerosis","longName":"3005325","preferredDefinition":"Dry skin","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE72-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CE8B-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"},{"value":"Edema","valueDescription":"Edema","ValueMeaning":{"publicId":"3005326","version":"1","preferredName":"Edema","longName":"3005326","preferredDefinition":"Pathological transudate within one or more tissues.(FMA)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE95-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CEAE-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"},{"value":"Nail dystrophy","valueDescription":"Nail dystrophy","ValueMeaning":{"publicId":"3005327","version":"1","preferredName":"Nail dystrophy","longName":"3005327","preferredDefinition":"Nail dystrophy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CEB8-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CED1-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"},{"value":"Erosions/Ulcerations","valueDescription":"Erosions/Ulcerations","ValueMeaning":{"publicId":"3005328","version":"1","preferredName":"Erosions/Ulcerations","longName":"3005328","preferredDefinition":"Erosions/Ulcerations","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CEDB-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CEF4-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"},{"value":"Pigmentation alteration","valueDescription":"Pigmentation Alteration","ValueMeaning":{"publicId":"3005329","version":"1","preferredName":"Pigmentation Alteration","longName":"3005329","preferredDefinition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.: A change resulting in something that is different from the original.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Alteration","conceptCode":"C28344","definition":"The act or process of modifying something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF01-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CF1A-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"},{"value":"Alopecia","valueDescription":"Alopecia","ValueMeaning":{"publicId":"2946575","version":"1","preferredName":"Alopecia","longName":"2946575","preferredDefinition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alopecia","conceptCode":"C50575","definition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74A54D4F-9F68-0EDF-E040-BB89AD430BAB","latestVersionIndicator":"Yes","beginDate":"2009-09-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-28","modifiedBy":"COOPERM","dateModified":"2020-04-16","changeDescription":"Updated definition to current NCIt. mc 4/16/20","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7EAB8C7C-CF24-328C-E040-BB89AD433B37","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3005323","version":"1","preferredName":"Skin Graft Versus Host Disease Sign Name","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.:An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.:Objective evidence of disease perceptible to the examining physician.:The words or language units by which a thing is known.","longName":"C12470:C3063:C53458:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sign","conceptCode":"C53458","definition":"Objective evidence of disease perceptible to the examining healthcare provider.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE4E-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE5F-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Objective ancillary date","type":"Preferred Question Text","description":"Objective ancillary date","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF2F-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeDescription":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}